Doxorubucin (DOX) and the cardioprotective agent, ICRF 187, have additive cytotoxicities for the murine sarcoma S180 cell line

S. Wadler, M. Green, D. Polsky, F. Muggia

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)No. 1350
JournalProceedings of the American Association for Cancer Research
VolumeVOL. 26
StatePublished - 1 Jan 1985
Externally publishedYes

ASJC Scopus subject areas

  • Medicine (all)

Cite this